Package 69097-844-02

{"route": ["ORAL"], "spl_id": "497e0a60-9b09-4dcc-8cc6-1f13196f2db4", "openfda": {"upc": ["0369097844073"], "unii": ["75046A1XTN"], "rxcui": ["861132"], "spl_set_id": ["3cc028d5-309f-4ce3-a2d7-5804ab57677d"], "manufacturer_name": ["Cipla USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (69097-844-02)", "package_ndc": "69097-844-02", "marketing_start_date": "20160630"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (69097-844-05)", "package_ndc": "69097-844-05", "marketing_start_date": "20160630"}, {"sample": false, "description": "100 TABLET in 1 BOTTLE (69097-844-07)", "package_ndc": "69097-844-07", "marketing_start_date": "20160630"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (69097-844-12)", "package_ndc": "69097-844-12", "marketing_start_date": "20160630"}], "brand_name": "Alfuzosin Hydrochloride extended release", "product_id": "69097-844_497e0a60-9b09-4dcc-8cc6-1f13196f2db4", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "69097-844", "generic_name": "Alfuzosin Hydrochloride", "labeler_name": "Cipla USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Alfuzosin Hydrochloride", "brand_name_suffix": "extended release", "active_ingredients": [{"name": "ALFUZOSIN HYDROCHLORIDE", "strength": "10 mg/1"}], "application_number": "ANDA090284", "marketing_category": "ANDA", "marketing_start_date": "20160630", "listing_expiration_date": "20261231"}